Organon & Co | OGN - Pre Tax Profit


Organon & Co reported $213M in Pre-Tax Profit for its fiscal quarter ending in March of 2026.





Pre Tax Profit Change Date
Bristol-Myers Squibb USD 4.99B 1.75B Jun/2026
Celltrion KRW 11.84B 1.34B Mar/2026
Cspc Pharmaceutical CNY 505.59M 706M Dec/2025
Dianthus Therapeutics USD -40.83M 23.6M Mar/2026
Divis Laboratories Ltd INR 11.8B 2.17B Jun/2026
Gilead Sciences USD -7.53B 10.11B Jun/2026
Glaxosmithkline GBP 2.14B 312M Mar/2026
Kangmei Pharma CNY -14.01M 16.08M Mar/2026
Knight Therapeutics CAD -1.92M 13.69M Sep/2025
Laboratorios Farma EUR 26.78M 94.77M Jun/2025
Medical Developments International AUD -149K 466K Jun/2025
Merck USD -3.53B 6.95B Mar/2026
Neuren Pharmaceuticals AUD 19.21M 9.35M Dec/2025
Novartis USD 3.84B 1.33B Mar/2026
Organigram Holdings CAD -921K 40.8M Mar/2026
Organon & Co USD 213M 361M Mar/2026
Pharma Mar EUR -993K 2.59M Jun/2026
Qiagen NV USD 85.83M 23.34M Mar/2026
Sartorius EUR 127M 30.8M Jun/2026
Tilray USD -39.96M 39.19M Sep/2025
Zealand Pharma A/S -394M 12.5M Mar/2026